1. Capital Formation: Equity, Dilution, and Investor Expectations
The equity structure you establish in the first funding round shapes every transaction that follows. Founders often assume they can adjust terms later, but investor agreements, option pools, and preferred stock classes create path dependencies that are difficult to unwind. From a practitioner's perspective, the most consequential decision is whether to grant preferred equity (with liquidation preferences and conversion rights) or to keep all equity common. This choice determines how much dilution founders face in future rounds and what control rights investors will demand.
Liquidation preferences merit particular attention. A 1x non-participating preference means investors recover their investment before founders see proceeds, but founders retain upside above that threshold. A 2x or 3x preference, or a participating preference that allows investors to recover their investment and then share in remaining proceeds, significantly reduces founder returns in a modest exit. Courts in New York have enforced liquidation preferences as written, even when they produce outcomes founders did not anticipate. In one representative case heard in Delaware Chancery Court (which often governs emerging companies incorporated there), shareholders challenged a preference structure that left them with minimal proceeds in a $50 million acquisition; the court enforced the agreement as drafted, finding no ambiguity in the terms.
| Preference Type | Founder Upside in $20M Exit | Investor Upside |
| 1x non-participating (common equity) | Shares in proceeds above $10M investment | $10M + percentage of remaining $10M |
| 1x participating | Reduced by investor participation in full proceeds | $10M + percentage of full $20M |
| 2x non-participating | Shares in proceeds above $20M (zero in this scenario) | $20M (full exit) |
Option Pool and Employee Equity
Set aside 10 to 20 percent of fully diluted equity for employee options before investors commit capital. Investors will demand this pool exist; if you grant it afterward, it dilutes their holdings retroactively and creates friction. The vesting schedule matters as much as the grant size. A four-year vest with a one-year cliff (employees receive nothing until year one, then vest monthly thereafter) is market standard and aligns incentives with long-term retention.
2. Emerging Companies and Growth: Governance and Shareholder Agreements
Governance structure determines how decisions are made, who has veto power, and what happens when founders disagree. This is where disputes most frequently arise. A board of directors (even a small one) creates accountability and separates founder judgment from shareholder interests. Without a board, every shareholder decision requires unanimous consent, which paralyzes the company when interests diverge.
Shareholder agreements and voting agreements lock in key terms. Drag-along rights allow majority shareholders to force minorities to sell in an acquisition. Tag-along rights give minorities the right to participate in a sale at the same price. Co-sale rights let founders maintain their ownership percentage in future funding rounds. These provisions sound abstract until a conflict emerges: a founder wants to sell, but a minority investor objects, or a new investor demands terms that dilute existing shareholders unevenly. Courts in New York will enforce these agreements, but only if the language is clear and the process was fair.
Our Emerging Growth Counsel practice focuses on structuring these agreements to prevent later disputes. The key is documenting founder intent early and ensuring all parties understand the consequences of their choices.
Founder Vesting and Equity Clawback
Founders often grant themselves 100 percent of equity upfront and assume they own it. Investors will require founder vesting, typically four years with a one-year cliff. This means if a founder leaves in year two, the company can repurchase unvested equity at the original grant price (usually $0.00 for founders). This protects the company if a founder departs early, but it also means founders do not truly own their equity until year four. Negotiate this early; do not discover it during due diligence for a Series A round.
3. Regulatory Compliance and Licensing
Regulatory exposure depends entirely on your business model. A software company faces different compliance requirements than a healthcare startup or a financial services firm. The mistake most founders make is assuming they can address compliance later, after they have product-market fit. Regulatory violations can halt operations, trigger fines, and make a company uninsurable or unmarketable to acquirers.
If your business involves regulated activities (financial services, healthcare, pharmaceuticals, telecommunications, or consumer data), engage counsel immediately. Do not wait until you have revenue. A healthcare technology startup, for example, must understand HIPAA requirements before collecting patient data. A fintech company must understand state money transmitter licensing, federal lending regulations, and SEC rules depending on whether it offers investment products. These are not minor compliance tasks; they determine whether your business model is viable.
New York Regulatory Filings and Department of State Requirements
If your company is incorporated or operates in New York, you must file Articles of Incorporation with the New York Department of State and maintain a registered agent. Annual filings are required, and failure to file triggers penalties and loss of good standing. More importantly, if your business involves regulated industries, New York has specific licensing requirements. The Department of Financial Services regulates insurance, lending, and certain financial products. The Department of Health regulates healthcare providers and facilities. The Public Service Commission regulates utilities and telecommunications. Non-compliance can result in cease-and-desist orders, fines, and criminal liability for officers. Courts in New York take regulatory violations seriously and will not enforce contracts or grant relief to companies operating without required licenses.
4. Emerging Companies and Growth: Practical Next Steps
The immediate priorities are straightforward. First, document your capital structure. List every investor, the amount invested, the class of equity, and the terms (preferences, conversion rights, and anti-dilution provisions). This becomes your cap table, and it must be accurate before you raise additional funding.
Second, establish a board of directors and hold regular meetings. Document decisions in board minutes. This creates a record that protects founders from personal liability and demonstrates governance to future investors.
Third, review your regulatory obligations. If you operate in a regulated industry, identify the specific licenses and compliance requirements that apply to your business. Do not assume your industry is unregulated; if you are uncertain, consult counsel.
Our Emerging Enterprise and Lifecycle Advisory practice helps founders navigate these decisions. The cost of getting the structure right now is far lower than the cost of restructuring later or defending disputes with investors and regulators.
As you scale, revisit these foundations regularly. Each funding round, each new hire, and each new market entry may require adjustments to your governance, equity structure, or regulatory compliance. The companies that scale most efficiently are those that treat legal structure as a strategic asset, not an afterthought.
30 Mar, 2026
